| Sep 18 |
Crispr Therapeutics: Prepare To Be Bored
|
| Sep 13 |
Crispr Therapeutics: Casgevy Now Active Across 35 Treatment Centres
|
| Sep 12 |
1 Biotech Stock Down 62% to Buy and Hold
|
| Sep 12 |
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
|
| Sep 10 |
CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why
|
| Sep 8 |
CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers
|
| Sep 5 |
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?
|
| Sep 4 |
Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report?
|
| Sep 2 |
3 Monster Biotech Stocks to Buy Before 2025
|
| Aug 26 |
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
|
